Cancer Immunotherapy Market Size by Global Major Companies Profile, Competitive Landscape and Key Regions 2023

“Global Cancer Immunotherapy Market” is Set to Capture a CAGR of 14.8% During the Forecast Period 2018-2023. The Market is Expected to Catapult from USD 36.8 Bn in 2018 to USD 101.6 Bn by 2023.

Market Segmentation:

According to Market Research Future, the global cancer immunotherapy market has been segmented by therapy types, by application, by end user.0

By the type, market segment includes monoclonal antibodies, adoptive cell transfer, cytokines, treatment vaccines, bacillus Calmette Guerin, and others. Further, monoclonal antibodies segment is segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies. Cytokines are further segmented into Interferon, Interleukins.

Get Exclusive Free Sample Copy @

By the application, the market is segmented into liver cancer, childhood cancer, colorectal cancer, stomach cancer, lung cancer and others.

By the end user, market is segmented into hospitals, clinics, and others.

Market Insights:

Market Research Future has released a new research report on global cancer immunotherapy market. the report takes a close look at its growth graph which is recorded to be at a CAGR of 14.8% and would achieve a valuation of USD 101.6 billion by 2023.

Cancer immunotherapy is another form of cancer treatment which boosts immune system in body to fight against cancer cell that spreads inside causing cancer. This kind of therapy prevents cancer to spread, reduce the growth of cancer cells and destroys the existing cell efficiently. Approximately 100 different types of cancer are identified, therefore cancer immunotherapies have been the best solution for cancer relief.

Key Players:

Market Research Future has listed some of key the players in the market, they are F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, GlaxoSmithKline Plc., Amgen Inc., Bristol-Myers Squibb, ELI Lilly and Company, Celgene Corporation, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc.

Global Cancer Immunotherapy Market: Drivers & Trends

Global cancer immunotherapy market has been growing at an impressive frequency in recent years and it is expected that it will maintain the same in the years to come. MRFR has also included a report which goes according to W.H.O., cancer is the leasing cause of deaths globally in the year 2015 which led to 8.8 million deaths in number. The statistics showed that nearly 1 in 6 patients die due to cancer, which causes with worsening of lifestyle including activities such as smoking and alcoholism. These incidences are responsible for cancer to grow. Therefore, increasing cancerous population is the one of the major driving factors for the global immunotherapy market in the recent years. Cancer immunotherapy is highly effective with less side effects therapy, as compared to the other ones.

The global cancer immunotherapy market is also proliferating in various regions owing to its effectiveness than the conventional treatments. Even the cancer immunotherapy market is expected to have high development in the coming years owing to launch of new treatment methods and drugs to cure cancer. There have been an increasing number of patient’s assistance program which is likely to boost the market for cancer immunotherapy.

Apart from this, the global cancer immunotherapy market is also up-surging with the requirement of cancer monoclonal antibodies. Also, with the launch of effective bioinformatics tools that offer improvised options of drug development is expected to complement the growth of global cancer immunotherapy market as well. On the other hand, the rise in adoption of immunotherapy therapeutics are increasing compared to the conventional therapeutics or traditional chemotherapy thus, boosting the global market.

The other factors influencing the global cancer immunotherapy is the rising number of R&D in various regions are thus, fueling the market growth. The best thing is that various emerging economies are approving the usage of immunotherapy therapeutics which is thus augmenting the global cancer immunotherapy market in positive ways and will garner at a rapid pace during the forecast period.

On the flip side, expensive development cost of new drugs in this market is thus hampering the growth. with that, poor infrastructure for cancer diagnosis and screening is envisioned to trouble the market growth in the coming years.

Browse Complete 85 Pages Premium Research Report Enabled with 76 Respective Tables and Figures at

Regional Outlook:

On a geographical note, the global cancer immunotherapy market has covered four main regions, they are North America, Europe, Asia Pacific and The Middle East and Africa.

The report portrays that since last few years, North America and Europe have been the major contributors in the global cancer immunotherapy market owing to their reputation as a suitable place for research and development. The market for cancer immunotherapy has a huge demand in both region and is expected to grow in the forecast period.

Whereas, Asia Pacific has been observed as the fastest growing cancer immunotherapy market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, swelling demand for new treatment methods in countries such as India and South Korea are likely to appear as the fastest growing cancer immunotherapy market across the globe. Then, the Middle East and Africa hold the least growth in comparison to other region, although, increasing occurrence of cancer owing to smoking, change in lifestyle, and excessive alcohol intake are driving the cancer immunotherapy market in this region.

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India
Phone: +1 646 845 9312

Release ID: 527309